Jordan, J. v. Lynde, M.

2024 Pa. Super. 315, 330 A.3d 817
CourtSuperior Court of Pennsylvania
DecidedDecember 31, 2024
Docket234 EDA 2024
StatusPublished

This text of 2024 Pa. Super. 315 (Jordan, J. v. Lynde, M.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jordan, J. v. Lynde, M., 2024 Pa. Super. 315, 330 A.3d 817 (Pa. Ct. App. 2024).

Opinion

J-A21004-24

2024 PA Super 315

JOANNE JORDAN AND STEPHEN : IN THE SUPERIOR COURT OF JORDAN : PENNSYLVANIA : Appellants : : v. : : MICHAEL LYNDE, D.P.M., JOHN : YOUSSEF, M.D., YOUVAL KATZ, : M.D., AND PENN HEMATOLOGY AND : ONCOLOGY : No. 234 EDA 2024

Appeal from the Order Entered December 13, 2023 In the Court of Common Pleas of Bucks County Civil Division at No(s): 2021-02616

BEFORE: KUNSELMAN, J., NICHOLS, J., and BECK, J.

OPINION BY KUNSELMAN, J.: FILED DECEMBER 31, 2024

In this medical-malpractice action, Joanne and Stephen Jordan appeal

from the order granting summary judgment to the Defendants, Michael Lynde,

D.P.M.; Penn Hematology and Oncology; John Youssef, M.D.; and Youval Katz,

M.D. Because the Jordans were not afforded the allowed 30 days under the

Rules of Civil Procedure to respond to Dr. Lynde’s motion for summary

judgment, we vacate the order as to Dr. Lynde. In all other respects, we

affirm.

In 2019, Mrs. Jordan was under the care of Penn Hematology and

Oncology, Dr. Youseff, and Dr. Katz (collectively, “Penn Hematology”). Penn

Hematology prescribed her blood thinners, including Coumadin.

She also had a bunion on her foot, which Dr. Lynde removed. He then

prescribed Mrs. Jordan the antibiotic Bactrim. Because Bactrim and Coumadin J-A21004-24

are contraindicated, Mrs. Jordan’s foot did not heal and became infected.

According to Mrs. Jordan, on May 22, 2019, she “was advised, for the first

time, there may have been an issue with her treatment, given her problematic

recovery, and in particular . . . the improper administration of Coumadin, a

blood thinner, while on Bactrim . . . .” Amended Complaint at 8.

Almost two years later, on May 19, 2021, the Jordans sued Dr. Lynde

and Penn Hematology. The matter proceeded to discovery, and, on October

26, 2023, Penn Hematology moved for summary judgment. It asked the trial

court to dismiss the case, because the Jordans failed (1) to provide an expert

report on Penn Hematology’s negligence and (2) to file suit within the statute

of limitations.1 The Jordans filed no response opposing the motion.

On December 5, 2023, Dr. Lynde filed a joinder in Penn Hematology’s

motion for summary judgment but only on the statute-of-limitations defense.

Eight days later, the trial court granted both motions for summary judgment.

This timely appeal followed.

The Jordans raise two issues:

1. Is summary judgment properly granted when (a) a party joins in a separate party’s motion, (b) the issues and facts differ among the moving parties, and (c) the respondent was not afforded 30 days to respond to the second/joining party’s motion?

2. Is summary judgment properly granted when (a) a party has granted the respondent additional time to respond to the motion, (b) the trial court is aware of the extension, (c)

____________________________________________

1 See 42 Pa.C.S.A. § 5524.

-2- J-A21004-24

the trial court seeks substantive information from counsel, and (d) the trial court rules upon the motion, nonetheless?

Jordans’ Brief at 4. We address each issue in turn.

Initially, the Jordans claim the trial court erred by granting Dr. Lynde’s

joinder motion for summary judgment without giving them 30 days to

respond. They argue Pa.R.C.P. 1035.3 allows 30 days for a party to respond

to a motion for summary judgment, as well as supplement the record. The

Jordans assert that this applies to a joinder motion, even if the joining

defendant’s summary-judgment theory is the same as the other defendants’

theory, because the applicable facts and law may vary from party to party.

In response, Dr. Lynde claims the trial court correctly granted summary

judgment, because he did not raise a new theory in his motion. In his view,

Pa.R.C.P. 1035.3(e) permits the trial court to rule on summary judgment at

any time, without written responses or briefs. 2

Generally, as the parties note, on an appeal from a summary judgment

order our scope and standard of review are plenary and de novo, respectively.

See Jordans’ Brief at 3; Lynde’s Brief at 2.

However, the drafters of Rule 1035.3 explicitly “provid[ed] that a court

has the discretion to rule on a motion for summary judgment at any time

prior to trial.” Pa.R.C.P. 1035.3, 2003 Comment (quotation omitted)

2 We note that Penn Hematology also responds to the Jordans’ first issue in

its brief. However, this issue is irrelevant to Penn Hematology, because the Jordans had 30 days to respond to its motion for summary judgment. Thus, we disregard Penn Hematology’s argument.

-3- J-A21004-24

(emphasis added). Hence, the issue before us is not whether the trial court

correctly applied the statute of limitations to the undisputed facts of record,

for which our standard of review would be de novo. Instead, the issue is

whether the trial court abused its discretion in applying Pa.R.C.P. 1035.3 by

granting summary judgment only eight days after Dr. Lynde filed his joinder

motion.

“Judicial discretion requires action in conformity with law on facts and

circumstances before the trial court after hearing and consideration.” Eaddy

v. Hamaty, 694 A.2d 639, 643 (Pa. Super. 1997). “An abuse of discretion is

not merely an error of judgment. Rather, a trial court abuses its discretion if,

in reaching a conclusion, the law is overridden or misapplied, or the judgment

exercised is manifestly unreasonable or lacking in reason.” Id.

When a party moves for summary judgment, the opposing party “may

not rest upon the mere allegations or denials of the pleadings but must file a

response within thirty days after service of the motion . . . .” Pa.R.C.P.

1035.3(a). The Jordans claim nothing in the Rule “permits a [moving] party

to shorten this 30-day deadline by merely joining in another party’s motion”

for summary judgment. Jordans’ Brief at 20. Based on our precedents, we

agree.

This Court has stated that Rule 1035.3(a) “allows 30 days for response.”

Eaddy, 694 A.2d at 643. In Eaddy, the “trial court did not afford [the

plaintiffs] 30 days to respond to defendant’s summary judgment motion.” Id.

We deemed this a misapplication of Rule 1035.3, because “the Rule allows the

-4- J-A21004-24

adverse party to ‘supplement the record or set forth the reasons why the party

cannot present evidence essential to justify opposition to the motion and any

action proposed to be taken by the party to present such evidence.’” Id.

(quoting Pa.R.C.P. 1035.3(b)). We explained in Eaddy, that by “failing to

apply the new rules governing summary-judgment motions and to follow

proper legal procedures, the trial court committed an abuse of discretion.” Id.

at 644. Accordingly, we vacated summary judgment and “remanded to the

trial court with directions that it allow [the plaintiffs] 30 days to respond to

defendant’s summary judgment motion and then proceed as contemplated by

[] Rules of Civil Procedure 1035.1 through 1035.5.” Id.

Eaddy is directly on point and controls the outcome of the Jordans’ first

issue. Dr. Lynde filed his motion for summary judgment, and the trial court

hastily granted it eight days later. The trial court did not give the Jordans 30

days to respond to Dr. Lynde’s motion or to supplement the record to counter

his motion.

The trial court and Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Eaddy v. Hamaty
694 A.2d 639 (Superior Court of Pennsylvania, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
2024 Pa. Super. 315, 330 A.3d 817, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jordan-j-v-lynde-m-pasuperct-2024.